img

Global Non-opioid Topical Pain Relief Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Non-opioid Topical Pain Relief Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Non-opioid Topical Pain Relief market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-opioid Topical Pain Relief market research.
Key manufacturers engaged in the Non-opioid Topical Pain Relief industry include Johnson and Johnson, GlaxoSmithKline, Pfizer, Hisamitsu, Mylan, Reckitt Benckiser Group, Sanofi, Teva Pharmaceutical and Sun Pharmaceutical Industries, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Non-opioid Topical Pain Relief were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Non-opioid Topical Pain Relief market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-opioid Topical Pain Relief market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Johnson and Johnson
GlaxoSmithKline
Pfizer
Hisamitsu
Mylan
Reckitt Benckiser Group
Sanofi
Teva Pharmaceutical
Sun Pharmaceutical Industries
Lingrui Pharmaceutical
Tibet Cheezheng Tibetan Medicine
China Resources Sanjiu Medical & Pharmaceutical
Topical BioMedics
AdvaCare Pharma
Abacus Health Products
Segment by Type
Prescription Pain Relief
Over-The-Counter Pain Relief

Segment by Application


Pharmacy
Clinic
Hospital
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Non-opioid Topical Pain Relief report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Non-opioid Topical Pain Relief Market Overview
1.1 Product Overview and Scope of Non-opioid Topical Pain Relief
1.2 Non-opioid Topical Pain Relief Segment by Type
1.2.1 Global Non-opioid Topical Pain Relief Market Value Comparison by Type (2024-2034)
1.2.2 Prescription Pain Relief
1.2.3 Over-The-Counter Pain Relief
1.3 Non-opioid Topical Pain Relief Segment by Application
1.3.1 Global Non-opioid Topical Pain Relief Market Value by Application: (2024-2034)
1.3.2 Pharmacy
1.3.3 Clinic
1.3.4 Hospital
1.3.5 Others
1.4 Global Non-opioid Topical Pain Relief Market Size Estimates and Forecasts
1.4.1 Global Non-opioid Topical Pain Relief Revenue 2024-2034
1.4.2 Global Non-opioid Topical Pain Relief Sales 2024-2034
1.4.3 Global Non-opioid Topical Pain Relief Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Non-opioid Topical Pain Relief Market Competition by Manufacturers
2.1 Global Non-opioid Topical Pain Relief Sales Market Share by Manufacturers (2024-2024)
2.2 Global Non-opioid Topical Pain Relief Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Non-opioid Topical Pain Relief Average Price by Manufacturers (2024-2024)
2.4 Global Non-opioid Topical Pain Relief Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Non-opioid Topical Pain Relief, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-opioid Topical Pain Relief, Product Type & Application
2.7 Non-opioid Topical Pain Relief Market Competitive Situation and Trends
2.7.1 Non-opioid Topical Pain Relief Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-opioid Topical Pain Relief Players Market Share by Revenue
2.7.3 Global Non-opioid Topical Pain Relief Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-opioid Topical Pain Relief Retrospective Market Scenario by Region
3.1 Global Non-opioid Topical Pain Relief Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Non-opioid Topical Pain Relief Global Non-opioid Topical Pain Relief Sales by Region: 2024-2034
3.2.1 Global Non-opioid Topical Pain Relief Sales by Region: 2024-2024
3.2.2 Global Non-opioid Topical Pain Relief Sales by Region: 2024-2034
3.3 Global Non-opioid Topical Pain Relief Global Non-opioid Topical Pain Relief Revenue by Region: 2024-2034
3.3.1 Global Non-opioid Topical Pain Relief Revenue by Region: 2024-2024
3.3.2 Global Non-opioid Topical Pain Relief Revenue by Region: 2024-2034
3.4 North America Non-opioid Topical Pain Relief Market Facts & Figures by Country
3.4.1 North America Non-opioid Topical Pain Relief Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Non-opioid Topical Pain Relief Sales by Country (2024-2034)
3.4.3 North America Non-opioid Topical Pain Relief Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-opioid Topical Pain Relief Market Facts & Figures by Country
3.5.1 Europe Non-opioid Topical Pain Relief Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Non-opioid Topical Pain Relief Sales by Country (2024-2034)
3.5.3 Europe Non-opioid Topical Pain Relief Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-opioid Topical Pain Relief Market Facts & Figures by Country
3.6.1 Asia Pacific Non-opioid Topical Pain Relief Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Non-opioid Topical Pain Relief Sales by Country (2024-2034)
3.6.3 Asia Pacific Non-opioid Topical Pain Relief Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-opioid Topical Pain Relief Market Facts & Figures by Country
3.7.1 Latin America Non-opioid Topical Pain Relief Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Non-opioid Topical Pain Relief Sales by Country (2024-2034)
3.7.3 Latin America Non-opioid Topical Pain Relief Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-opioid Topical Pain Relief Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-opioid Topical Pain Relief Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Non-opioid Topical Pain Relief Sales by Country (2024-2034)
3.8.3 Middle East and Africa Non-opioid Topical Pain Relief Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-opioid Topical Pain Relief Sales by Type (2024-2034)
4.1.1 Global Non-opioid Topical Pain Relief Sales by Type (2024-2024)
4.1.2 Global Non-opioid Topical Pain Relief Sales by Type (2024-2034)
4.1.3 Global Non-opioid Topical Pain Relief Sales Market Share by Type (2024-2034)
4.2 Global Non-opioid Topical Pain Relief Revenue by Type (2024-2034)
4.2.1 Global Non-opioid Topical Pain Relief Revenue by Type (2024-2024)
4.2.2 Global Non-opioid Topical Pain Relief Revenue by Type (2024-2034)
4.2.3 Global Non-opioid Topical Pain Relief Revenue Market Share by Type (2024-2034)
4.3 Global Non-opioid Topical Pain Relief Price by Type (2024-2034)
5 Segment by Application
5.1 Global Non-opioid Topical Pain Relief Sales by Application (2024-2034)
5.1.1 Global Non-opioid Topical Pain Relief Sales by Application (2024-2024)
5.1.2 Global Non-opioid Topical Pain Relief Sales by Application (2024-2034)
5.1.3 Global Non-opioid Topical Pain Relief Sales Market Share by Application (2024-2034)
5.2 Global Non-opioid Topical Pain Relief Revenue by Application (2024-2034)
5.2.1 Global Non-opioid Topical Pain Relief Revenue by Application (2024-2024)
5.2.2 Global Non-opioid Topical Pain Relief Revenue by Application (2024-2034)
5.2.3 Global Non-opioid Topical Pain Relief Revenue Market Share by Application (2024-2034)
5.3 Global Non-opioid Topical Pain Relief Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Johnson and Johnson
6.1.1 Johnson and Johnson Corporation Information
6.1.2 Johnson and Johnson Description and Business Overview
6.1.3 Johnson and Johnson Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Johnson and Johnson Non-opioid Topical Pain Relief Product Portfolio
6.1.5 Johnson and Johnson Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2024-2024)
6.2.4 GlaxoSmithKline Non-opioid Topical Pain Relief Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Pfizer Non-opioid Topical Pain Relief Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Hisamitsu
6.4.1 Hisamitsu Corporation Information
6.4.2 Hisamitsu Description and Business Overview
6.4.3 Hisamitsu Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Hisamitsu Non-opioid Topical Pain Relief Product Portfolio
6.4.5 Hisamitsu Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Mylan Non-opioid Topical Pain Relief Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Reckitt Benckiser Group
6.6.1 Reckitt Benckiser Group Corporation Information
6.6.2 Reckitt Benckiser Group Description and Business Overview
6.6.3 Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Reckitt Benckiser Group Non-opioid Topical Pain Relief Product Portfolio
6.6.5 Reckitt Benckiser Group Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Sanofi Non-opioid Topical Pain Relief Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Teva Pharmaceutical
6.8.1 Teva Pharmaceutical Corporation Information
6.8.2 Teva Pharmaceutical Description and Business Overview
6.8.3 Teva Pharmaceutical Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Teva Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio
6.8.5 Teva Pharmaceutical Recent Developments/Updates
6.9 Sun Pharmaceutical Industries
6.9.1 Sun Pharmaceutical Industries Corporation Information
6.9.2 Sun Pharmaceutical Industries Description and Business Overview
6.9.3 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product Portfolio
6.9.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.10 Lingrui Pharmaceutical
6.10.1 Lingrui Pharmaceutical Corporation Information
6.10.2 Lingrui Pharmaceutical Description and Business Overview
6.10.3 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio
6.10.5 Lingrui Pharmaceutical Recent Developments/Updates
6.11 Tibet Cheezheng Tibetan Medicine
6.11.1 Tibet Cheezheng Tibetan Medicine Corporation Information
6.11.2 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Description and Business Overview
6.11.3 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product Portfolio
6.11.5 Tibet Cheezheng Tibetan Medicine Recent Developments/Updates
6.12 China Resources Sanjiu Medical & Pharmaceutical
6.12.1 China Resources Sanjiu Medical & Pharmaceutical Corporation Information
6.12.2 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Description and Business Overview
6.12.3 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2024-2024)
6.12.4 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio
6.12.5 China Resources Sanjiu Medical & Pharmaceutical Recent Developments/Updates
6.13 Topical BioMedics
6.13.1 Topical BioMedics Corporation Information
6.13.2 Topical BioMedics Non-opioid Topical Pain Relief Description and Business Overview
6.13.3 Topical BioMedics Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Topical BioMedics Non-opioid Topical Pain Relief Product Portfolio
6.13.5 Topical BioMedics Recent Developments/Updates
6.14 AdvaCare Pharma
6.14.1 AdvaCare Pharma Corporation Information
6.14.2 AdvaCare Pharma Non-opioid Topical Pain Relief Description and Business Overview
6.14.3 AdvaCare Pharma Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2024-2024)
6.14.4 AdvaCare Pharma Non-opioid Topical Pain Relief Product Portfolio
6.14.5 AdvaCare Pharma Recent Developments/Updates
6.15 Abacus Health Products
6.15.1 Abacus Health Products Corporation Information
6.15.2 Abacus Health Products Non-opioid Topical Pain Relief Description and Business Overview
6.15.3 Abacus Health Products Non-opioid Topical Pain Relief Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Abacus Health Products Non-opioid Topical Pain Relief Product Portfolio
6.15.5 Abacus Health Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-opioid Topical Pain Relief Industry Chain Analysis
7.2 Non-opioid Topical Pain Relief Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-opioid Topical Pain Relief Production Mode & Process
7.4 Non-opioid Topical Pain Relief Sales and Marketing
7.4.1 Non-opioid Topical Pain Relief Sales Channels
7.4.2 Non-opioid Topical Pain Relief Distributors
7.5 Non-opioid Topical Pain Relief Customers
8 Non-opioid Topical Pain Relief Market Dynamics
8.1 Non-opioid Topical Pain Relief Industry Trends
8.2 Non-opioid Topical Pain Relief Market Drivers
8.3 Non-opioid Topical Pain Relief Market Challenges
8.4 Non-opioid Topical Pain Relief Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Non-opioid Topical Pain Relief Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Non-opioid Topical Pain Relief Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Non-opioid Topical Pain Relief Market Competitive Situation by Manufacturers in 2022
Table 4. Global Non-opioid Topical Pain Relief Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Non-opioid Topical Pain Relief Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Non-opioid Topical Pain Relief Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Non-opioid Topical Pain Relief Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Non-opioid Topical Pain Relief Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Non-opioid Topical Pain Relief, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Non-opioid Topical Pain Relief, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-opioid Topical Pain Relief, Product Type & Application
Table 12. Global Key Manufacturers of Non-opioid Topical Pain Relief, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-opioid Topical Pain Relief by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Topical Pain Relief as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-opioid Topical Pain Relief Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Non-opioid Topical Pain Relief Sales by Region (2024-2024) & (K Units)
Table 18. Global Non-opioid Topical Pain Relief Sales Market Share by Region (2024-2024)
Table 19. Global Non-opioid Topical Pain Relief Sales by Region (2024-2034) & (K Units)
Table 20. Global Non-opioid Topical Pain Relief Sales Market Share by Region (2024-2034)
Table 21. Global Non-opioid Topical Pain Relief Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Non-opioid Topical Pain Relief Revenue Market Share by Region (2024-2024)
Table 23. Global Non-opioid Topical Pain Relief Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Non-opioid Topical Pain Relief Revenue Market Share by Region (2024-2034)
Table 25. North America Non-opioid Topical Pain Relief Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Non-opioid Topical Pain Relief Sales by Country (2024-2024) & (K Units)
Table 27. North America Non-opioid Topical Pain Relief Sales by Country (2024-2034) & (K Units)
Table 28. North America Non-opioid Topical Pain Relief Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Non-opioid Topical Pain Relief Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Non-opioid Topical Pain Relief Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Non-opioid Topical Pain Relief Sales by Country (2024-2024) & (K Units)
Table 32. Europe Non-opioid Topical Pain Relief Sales by Country (2024-2034) & (K Units)
Table 33. Europe Non-opioid Topical Pain Relief Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Non-opioid Topical Pain Relief Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Non-opioid Topical Pain Relief Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Non-opioid Topical Pain Relief Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Non-opioid Topical Pain Relief Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Non-opioid Topical Pain Relief Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Non-opioid Topical Pain Relief Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Non-opioid Topical Pain Relief Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Non-opioid Topical Pain Relief Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Non-opioid Topical Pain Relief Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Non-opioid Topical Pain Relief Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Non-opioid Topical Pain Relief Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Non-opioid Topical Pain Relief Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Non-opioid Topical Pain Relief Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Non-opioid Topical Pain Relief Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Non-opioid Topical Pain Relief Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Non-opioid Topical Pain Relief Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Non-opioid Topical Pain Relief Sales (K Units) by Type (2024-2024)
Table 51. Global Non-opioid Topical Pain Relief Sales (K Units) by Type (2024-2034)
Table 52. Global Non-opioid Topical Pain Relief Sales Market Share by Type (2024-2024)
Table 53. Global Non-opioid Topical Pain Relief Sales Market Share by Type (2024-2034)
Table 54. Global Non-opioid Topical Pain Relief Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Non-opioid Topical Pain Relief Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Non-opioid Topical Pain Relief Revenue Market Share by Type (2024-2024)
Table 57. Global Non-opioid Topical Pain Relief Revenue Market Share by Type (2024-2034)
Table 58. Global Non-opioid Topical Pain Relief Price (US$/Unit) by Type (2024-2024)
Table 59. Global Non-opioid Topical Pain Relief Price (US$/Unit) by Type (2024-2034)
Table 60. Global Non-opioid Topical Pain Relief Sales (K Units) by Application (2024-2024)
Table 61. Global Non-opioid Topical Pain Relief Sales (K Units) by Application (2024-2034)
Table 62. Global Non-opioid Topical Pain Relief Sales Market Share by Application (2024-2024)
Table 63. Global Non-opioid Topical Pain Relief Sales Market Share by Application (2024-2034)
Table 64. Global Non-opioid Topical Pain Relief Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Non-opioid Topical Pain Relief Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Non-opioid Topical Pain Relief Revenue Market Share by Application (2024-2024)
Table 67. Global Non-opioid Topical Pain Relief Revenue Market Share by Application (2024-2034)
Table 68. Global Non-opioid Topical Pain Relief Price (US$/Unit) by Application (2024-2024)
Table 69. Global Non-opioid Topical Pain Relief Price (US$/Unit) by Application (2024-2034)
Table 70. Johnson and Johnson Corporation Information
Table 71. Johnson and Johnson Description and Business Overview
Table 72. Johnson and Johnson Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Johnson and Johnson Non-opioid Topical Pain Relief Product
Table 74. Johnson and Johnson Recent Developments/Updates
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Business Overview
Table 77. GlaxoSmithKline Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. GlaxoSmithKline Non-opioid Topical Pain Relief Product
Table 79. GlaxoSmithKline Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Pfizer Non-opioid Topical Pain Relief Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Hisamitsu Corporation Information
Table 86. Hisamitsu Description and Business Overview
Table 87. Hisamitsu Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Hisamitsu Non-opioid Topical Pain Relief Product
Table 89. Hisamitsu Recent Developments/Updates
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Mylan Non-opioid Topical Pain Relief Product
Table 94. Mylan Recent Developments/Updates
Table 95. Reckitt Benckiser Group Corporation Information
Table 96. Reckitt Benckiser Group Description and Business Overview
Table 97. Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Reckitt Benckiser Group Non-opioid Topical Pain Relief Product
Table 99. Reckitt Benckiser Group Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Sanofi Non-opioid Topical Pain Relief Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Teva Pharmaceutical Corporation Information
Table 106. Teva Pharmaceutical Description and Business Overview
Table 107. Teva Pharmaceutical Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Teva Pharmaceutical Non-opioid Topical Pain Relief Product
Table 109. Teva Pharmaceutical Recent Developments/Updates
Table 110. Sun Pharmaceutical Industries Corporation Information
Table 111. Sun Pharmaceutical Industries Description and Business Overview
Table 112. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product
Table 114. Sun Pharmaceutical Industries Recent Developments/Updates
Table 115. Lingrui Pharmaceutical Corporation Information
Table 116. Lingrui Pharmaceutical Description and Business Overview
Table 117. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product
Table 119. Lingrui Pharmaceutical Recent Developments/Updates
Table 120. Tibet Cheezheng Tibetan Medicine Corporation Information
Table 121. Tibet Cheezheng Tibetan Medicine Description and Business Overview
Table 122. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product
Table 124. Tibet Cheezheng Tibetan Medicine Recent Developments/Updates
Table 125. China Resources Sanjiu Medical & Pharmaceutical Corporation Information
Table 126. China Resources Sanjiu Medical & Pharmaceutical Description and Business Overview
Table 127. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product
Table 129. China Resources Sanjiu Medical & Pharmaceutical Recent Developments/Updates
Table 130. Topical BioMedics Corporation Information
Table 131. Topical BioMedics Description and Business Overview
Table 132. Topical BioMedics Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Topical BioMedics Non-opioid Topical Pain Relief Product
Table 134. Topical BioMedics Recent Developments/Updates
Table 135. AdvaCare Pharma Corporation Information
Table 136. AdvaCare Pharma Description and Business Overview
Table 137. AdvaCare Pharma Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. AdvaCare Pharma Non-opioid Topical Pain Relief Product
Table 139. AdvaCare Pharma Recent Developments/Updates
Table 140. Abacus Health Products Corporation Information
Table 141. Abacus Health Products Description and Business Overview
Table 142. Abacus Health Products Non-opioid Topical Pain Relief Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Abacus Health Products Non-opioid Topical Pain Relief Product
Table 144. Abacus Health Products Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Non-opioid Topical Pain Relief Distributors List
Table 148. Non-opioid Topical Pain Relief Customers List
Table 149. Non-opioid Topical Pain Relief Market Trends
Table 150. Non-opioid Topical Pain Relief Market Drivers
Table 151. Non-opioid Topical Pain Relief Market Challenges
Table 152. Non-opioid Topical Pain Relief Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-opioid Topical Pain Relief
Figure 2. Global Non-opioid Topical Pain Relief Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Non-opioid Topical Pain Relief Market Share by Type in 2022 & 2034
Figure 4. Prescription Pain Relief Product Picture
Figure 5. Over-The-Counter Pain Relief Product Picture
Figure 6. Global Non-opioid Topical Pain Relief Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Non-opioid Topical Pain Relief Market Share by Application in 2022 & 2034
Figure 8. Pharmacy
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Global Non-opioid Topical Pain Relief Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global Non-opioid Topical Pain Relief Market Size (2024-2034) & (US$ Million)
Figure 14. Global Non-opioid Topical Pain Relief Sales (2024-2034) & (K Units)
Figure 15. Global Non-opioid Topical Pain Relief Average Price (US$/Unit) & (2024-2034)
Figure 16. Non-opioid Topical Pain Relief Report Years Considered
Figure 17. Non-opioid Topical Pain Relief Sales Share by Manufacturers in 2022
Figure 18. Global Non-opioid Topical Pain Relief Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Non-opioid Topical Pain Relief Players: Market Share by Revenue in 2022
Figure 20. Non-opioid Topical Pain Relief Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 21. Global Non-opioid Topical Pain Relief Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 22. North America Non-opioid Topical Pain Relief Sales Market Share by Country (2024-2034)
Figure 23. North America Non-opioid Topical Pain Relief Revenue Market Share by Country (2024-2034)
Figure 24. United States Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Canada Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 26. Europe Non-opioid Topical Pain Relief Sales Market Share by Country (2024-2034)
Figure 27. Europe Non-opioid Topical Pain Relief Revenue Market Share by Country (2024-2034)
Figure 28. Germany Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. France Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. U.K. Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Italy Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Russia Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Asia Pacific Non-opioid Topical Pain Relief Sales Market Share by Region (2024-2034)
Figure 34. Asia Pacific Non-opioid Topical Pain Relief Revenue Market Share by Region (2024-2034)
Figure 35. China Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Japan Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. South Korea Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. India Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Australia Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. China Taiwan Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Southeast Asia Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Latin America Non-opioid Topical Pain Relief Sales Market Share by Country (2024-2034)
Figure 43. Latin America Non-opioid Topical Pain Relief Revenue Market Share by Country (2024-2034)
Figure 44. Mexico Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Brazil Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Argentina Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Middle East & Africa Non-opioid Topical Pain Relief Sales Market Share by Country (2024-2034)
Figure 48. Middle East & Africa Non-opioid Topical Pain Relief Revenue Market Share by Country (2024-2034)
Figure 49. Turkey Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Saudi Arabia Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. UAE Non-opioid Topical Pain Relief Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Non-opioid Topical Pain Relief by Type (2024-2034)
Figure 53. Global Revenue Market Share of Non-opioid Topical Pain Relief by Type (2024-2034)
Figure 54. Global Non-opioid Topical Pain Relief Price (US$/Unit) by Type (2024-2034)
Figure 55. Global Sales Market Share of Non-opioid Topical Pain Relief by Application (2024-2034)
Figure 56. Global Revenue Market Share of Non-opioid Topical Pain Relief by Application (2024-2034)
Figure 57. Global Non-opioid Topical Pain Relief Price (US$/Unit) by Application (2024-2034)
Figure 58. Non-opioid Topical Pain Relief Value Chain
Figure 59. Non-opioid Topical Pain Relief Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed